Legal Representation
Attorney
Emily A. Bayton
USPTO Deadlines
Next Deadline
3226 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2014-06-03)
Due Date
June 03, 2034
Grace Period Ends
December 03, 2034
Application History
41 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 27, 2024 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
| Feb 27, 2024 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | Loading... |
| Feb 27, 2024 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | Loading... |
| Feb 9, 2024 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | Loading... |
| Jan 25, 2024 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jan 25, 2024 | PR89 | O | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 | Loading... |
| Jul 27, 2023 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
| Jun 3, 2023 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Sep 11, 2019 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Sep 11, 2019 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Sep 11, 2019 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Jul 31, 2019 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Jun 11, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 11, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 3, 2019 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jan 17, 2018 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jun 3, 2014 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 29, 2014 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 28, 2014 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Apr 28, 2014 | REGV | O | LAW OFFICE REGISTRATION REVIEW COMPLETED | Loading... |
| Apr 10, 2014 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Apr 7, 2014 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 15, 2014 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 15, 2014 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Nov 12, 2013 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 17, 2013 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 17, 2013 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 28, 2013 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 9, 2013 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Aug 8, 2013 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 26, 2013 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 26, 2013 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 26, 2013 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 26, 2013 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 26, 2013 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 29, 2013 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 29, 2013 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 29, 2013 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 26, 2013 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 21, 2013 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Mar 21, 2013 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 035
Specialty retail pharmacy services, namely, providing retail pharmacy services featuring hemophilia and related biological and pharmaceutical products to healthcare and medical plan providers for use by patients
First Use Anywhere:
Mar 27, 2013
First Use in Commerce:
May 9, 2013
Classification
International Classes
035
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"RX"